APOE and Alzheimer disease: In addition, the LRP/LDL receptor-binding domain of ApoE (residues 134–150) [36] corresponds exactly to the C-terminal end of ApoE1–151 to which our nApoECF antibody recognizes and labels nuclei in the AD brain.